Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
6
days
Subphenotypes of Sickle Cell Disease: A Guide to Targeting Treatment?
Authors
Martin H. SteinbergShow moreShow less
Affiliations
1. Division of Hematology and Medical Oncology Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts USAShow moreShow less
129
days
Identification of Clinical Sub‐Phenotypes of Sickle Cell Disease Using Latent Class Analysis
Authors
Shaina M. Willen; Ann M. Brunson; Oyebimpe O. Adesina; Ted WunShow moreShow less
Affiliations
1. Divisions of Pulmonary Medicine and Hematology/Oncology, Department of Pediatrics University of California Davis Sacramento California USA; 2. Center for Oncology Hematology Outcomes Research and Training, Division of Hematology and Oncology University of California Davis Comprehensive Cancer Center Sacramento California USAShow moreShow less
44
days
Autoantibodies to Extracellular Erythrocyte Band 3 Epitopes Are Associated With Anemia in Plasmodium vivax Infection
Authors
Aline Marzano‐Miranda; Vanessa G. Fraga; Cor Jésus F. Fontes; Simone Ladeia‐Andrade; Marcelo U. Ferreira; Daniella C. Bartholomeu; Érika M. BragaShow moreShow less
Affiliations
1. Department of Parasitology Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil; 2. School of Medical Sciences Federal University of Mato Grosso Cuiabá Mato Grosso Brazil; 3. Laboratory of Parasitic Diseases Oswaldo Cruz Institute, Fiocruz Rio de Janeiro Brazil; 4. Department of Parasitology Institute of Biomedical Sciences, University of São Paulo São Paulo BrazilShow moreShow less
33
days
p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases
Authors
Hong Fang; Joseph D. Khoury; Zhenya Tang; Sa A. Wang; Courtney D. DiNardo; Sanam Loghavi; Wei J. Wang; Yiannis Petros Dimopoulos; Shimin Hu; C. Cameron Yin; Siba El Hussein; Hui Zhang; Jayastu Senapati; Kelly Chien; Michael Andreeff; L. Jeffrey Medeiros; Wei WangShow moreShow less
Affiliations
1. Department of Hematopathology University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Department of Pathology, Microbiology and Immunology University of Nebraska Medical Center Omaha Nebraska USA; 3. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas USA; 4. Department of Pathology University of Vermont Larner College of Medicine Burlington Vermont USAShow moreShow less
63
days
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion‐Dependent Thalassemia
Authors
Anthony Iscaro; Simona Leoni; Filippo Russo; Valentina Brancaleoni; Barbara Eleni Rosato; Roberta Marra; Antonella Nostroso; Natalia Scaramellini; Daniele Lello Panzieri; Iris Villa; Teresa Ceglie; Carmen Maria Gaglioti; Neha Kargutkar; Vito Alessandro Lasorsa; Mario Capasso; Giovanni Battista Ferrero; Immacolata Andolfo; Irene Motta; Roberta RussoShow moreShow less
Affiliations
1. Dipartimento di Medicina Molecolare e Biotecnologie Mediche Università degli Studi di Napoli Federico II Naples Italy; 2. CEINGE Biotecnologie Avanzate Franco Salvatore Naples Italy; 3. Dipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023–2027 University of Milan Milan Italy; 4. SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy; 5. University of Milan Milan Italy; 6. Department of Clinical and Biological Sciences University of Turin Turin ItalyShow moreShow less
3
days
Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management
Authors
Guillermo Garcia‐ManeroShow moreShow less
Affiliations
1. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days